Golf, Koo and Toinv, to me the common thread of your last posts is business development or in the case RVX of a complete absence of business development. To me when the only thing listed as "accomplishment" regarding bd in the last presentation was the free licensing agreement they gave to the Israeli company that is incredibly sad. I hope they are chasing down leads regarding Covid but past the PR we have seen and heard no evidence of anything actually happening. I fear it will be the same as AIDS, quality outside research almost 3 years ago followed by talk that money for a trial was "sourced" followed by nothing. Same as the management checklist of a number of years ago.  If I recall correctly 6-8 legitimate goals (licensing deals for $, partnerships for new compounds etc), follow up zero and it just fell off the table. No further discussion on the list.

I'm not sure what the business development folks at RVX do all day but results would suggest it has very little to do with RVX.